Article
Pharmacological treatment of the basic defect in cystic fibrosis.
Cell biology international - 1 Nov 2014
Roomans Godfried M
Abstract excerpt
Cystic fibrosis (CF) is a genetic disease due to a mutation in the cystic fibrosis transmembrane conductance regulator (CFTR), a chloride channel in epithelial cells. There are about 1900 mutations, divided in several groups, for example, stop mutations, mutations affecting the permeability of the channel, and mutations in which the mutated CFTR is recognized as abnormal and destroyed. Pharmacological treatment...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
